1. Home
  2. NVAX vs ASTH Comparison

NVAX vs ASTH Comparison

Compare NVAX & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.30

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$21.23

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
ASTH
Founded
1987
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NVAX
ASTH
Price
$8.30
$21.23
Analyst Decision
Hold
Strong Buy
Analyst Count
9
9
Target Price
$10.78
$40.78
AVG Volume (30 Days)
6.4M
556.3K
Earning Date
02-26-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.07
0.20
Revenue
$1,064,651,000.00
$2,896,452,000.00
Revenue This Year
$58.91
$58.46
Revenue Next Year
N/A
$25.59
P/E Ratio
$4.20
$114.25
Revenue Growth
20.27
68.17
52 Week Low
$5.01
$20.12
52 Week High
$10.65
$39.97

Technical Indicators

Market Signals
Indicator
NVAX
ASTH
Relative Strength Index (RSI) 49.48 35.21
Support Level $9.16 $20.50
Resistance Level $10.20 $23.34
Average True Range (ATR) 0.69 1.56
MACD -0.09 -0.68
Stochastic Oscillator 22.67 8.67

Price Performance

Historical Comparison
NVAX
ASTH

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Share on Social Networks: